我们非常高兴的宣布，随着最新一年的影响因子发布，德孚旗下又有 3 本期刊喜获影响因子，他们分别是 Nature and Science of Sleep（2018 年影响因子：3.054），Pharmacogenomics and Personalized Medicine（2018 年影响因子：2.721），Risk Management and Healthcare Policy（2018 年影响因子：2.283）。至此，德孚期刊旗下共有17本期刊进入 SCI  期刊行列。

以下是这些期刊的名录：

1. Cancer Management and Research 2.243 
2. Clinical Epidemiology 3.178 
3. Clinical Interventions in Aging 2.585 (5 year impact 3.195) 
4. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 3.319 
5. Drug Design, Development and Therapy 3.208 (5 year impact 3.254) 
6. Infection and Drug Resistance 3.000 
7. International Journal of Chronic Obstructive Pulmonary Disease 3.274 (5 year impact 3.553)
8. International Journal of Nanomedicine 4.471 (5 year impact 5.029) 
9. Journal of Pain Research 2.236 (5 year impact 2.558) 
10. Nature and Science of Sleep 3.054 *New* 
11. Neuropsychiatric Disease and Treatment 2.228 (5 year impact 2.673) 
12. OncoTargets and Therapy 3.046 (5 year impact 2.968) 
13. Patient Preference and Adherence 2.097 (5 year impact 2.234) 
14. Pharmacogenomics and Personalized Medicine 2.721 *New* 
15. Psychology Research and Behavior Management 1.840 
16. Risk Management and Healthcare Policy 2.283 *New* 
17. Therapeutics and Clinical Risk Management 1.824 (5 year impact 2.050)